Suppr超能文献

超广谱β-内酰胺酶Toho-1的E166A突变体在1.8埃分辨率下的晶体结构。

Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 A resolution.

作者信息

Ibuka A, Taguchi A, Ishiguro M, Fushinobu S, Ishii Y, Kamitori S, Okuyama K, Yamaguchi K, Konno M, Matsuzawa H

机构信息

Department of Biotechnology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan.

出版信息

J Mol Biol. 1999 Feb 5;285(5):2079-87. doi: 10.1006/jmbi.1998.2432.

Abstract

Bacterial resistance to beta-lactams is mainly due to the production of beta-lactamase. Especially through the production of extended-spectrum beta-lactamases (ESBLs), bacteria have acquired resistance not only to penicillins, but also to expanded-spectrum cephems. Here, we describe the crystal structure of the E166A mutant of class A beta-lactamase Toho-1 at 1.8 A resolution, the first reported tertiary structure of an ESBL. Instead of the wild-type enzyme, a mutant Toho-1, in which Glu166 was replaced with alanine, was used for this study, because of the strong tendency of the wild-type enzyme to form twinned crystals. The overall structure of Toho-1 is similar to the crystal structures of non-ESBLs, with no pronounced backbone rearrangement of the framework. However, there are some notable local changes. First, a difference in the disposition of an arginine residue, which is at position 244 in non-ESBLs but at position 276 in Toho-1 and other ESBLs, was revealed and the role of this arginine residue is discussed. Moreover, changes in the hydrogen-bonding pattern and in the formation of the hydrophobic core were also observed near the Omega loop. In particular, the lack of hydrogen bonds in the vicinity of the Omega loop could be a cause of the extended substrate specificity of Toho-1. Through the generation of a model for the enzyme-substrate complex, a conformational change of Toho-1 occurring on complex formation is discussed based on the active-site cleft structure and the substrate profile.

摘要

细菌对β-内酰胺类药物的耐药性主要归因于β-内酰胺酶的产生。特别是通过产生超广谱β-内酰胺酶(ESBLs),细菌不仅对青霉素产生了耐药性,而且对广谱头孢菌素也产生了耐药性。在此,我们描述了A类β-内酰胺酶Toho-1的E166A突变体在1.8埃分辨率下的晶体结构,这是首次报道的ESBL的三级结构。由于野生型酶强烈倾向于形成孪晶,本研究使用的是将Glu166替换为丙氨酸的突变体Toho-1,而非野生型酶。Toho-1的整体结构与非ESBLs的晶体结构相似,框架结构没有明显的主链重排。然而,存在一些显著的局部变化。首先,揭示了精氨酸残基位置的差异,该残基在非ESBLs中位于244位,而在Toho-1和其他ESBLs中位于276位,并讨论了该精氨酸残基的作用。此外,在Ω环附近还观察到氢键模式和疏水核心形成的变化。特别是,Ω环附近缺乏氢键可能是Toho-1底物特异性扩展的原因。通过生成酶-底物复合物模型,基于活性位点裂隙结构和底物谱讨论了复合物形成时Toho-1发生的构象变化。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验